In the last six months Pfizer’s stock (NYSE: PFE) has underperformed Merck (NYSE: MRK) and J&J (NYSE: JNJ) primarily due to ...

Merck is no longer in discussions to buy cancer drug developer Revolution Medicines , the Wall Street Journal reported on ...

Merck & Co. will build a $3 billion pharmaceutical manufacturing facility in Elkton, Va. The new site is expected to create 500 jobs, Virginia Gov. Glenn Youngkin and the company announced at a ...

Merck & Co. logo displayed on the exterior of their research facility in San Francisco, Calif., on Sep. 21, 2020. This story was originally published on BioPharma Dive. To receive daily news and ...

Halozyme HALO0.47%increase; green up pointing triangle was granted a preliminary injunction that would prevent Merck MRK-0.41%decrease; red down pointing triangle & Co. from distributing a formulation ...

Halozyme was granted a preliminary injunction that would prevent Merck & Co. from distributing a formulation of Keytruda in Germany as part of a patent-infringement dispute over the cancer treatment.

Nov 4 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences (BX.N), opens new tab for $700 million to ...

Merck & Co., Inc. (NYSE:MRK) stock traded in a volatile session on Thursday following its third-quarter earnings report and updated fiscal 2025 outlook. The pharma giant reported adjusted earnings per ...

Merck & Co. shaved the top end of its 2025 revenue guidance and failed to produce any standout sales beats for its medicines in the third quarter, adding to challenges the drugmaker is facing as it ...

On Tuesday, Merck & Co. Inc. (NYSE:MRK) and Eisai shared topline data from the Phase 3 LITESPARK-011 trial of the dual oral regimen of Welireg (belzutifan) plus Lenvima (lenvatinib). The trial met one ...

Merck & Co., Inc. faces a pivotal Q3 earnings report as Keytruda's patent expiration looms and pipeline diversification efforts accelerate. MRK's oncology pipeline, including Keytruda Qlex and ...

Merck & Co. will build a $3 billion pharmaceutical manufacturing facility in Elkton that is expected to create 500 jobs, Gov. Glenn Youngkin and the company announced at a ceremonial groundbreaking ...